|
Randomized phase IIb clinical trial of continuation or non-continuation with six cycles of temozolomide after the first six cycles of standard first-line treatment in patients with glioblastoma: A Spanish research group in neuro-oncology (GEINO) trial. |
|
|
Consulting or Advisory Role - Abbvie; Celgene |
Travel, Accommodations, Expenses - Abbvie; Pfizer; Pfizer; SERVIER |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Celgene |
Travel, Accommodations, Expenses - Amgen; Sanofi/Aventis |
|
|
Honoraria - Bristol-Myers Squibb; LEO Pharma; Novartis; Pfizer; Roche |
Travel, Accommodations, Expenses - Aventis Pharma; Bristol-Myers Squibb; Ipsen; LEO Pharma; MSD; Novartis; Pfizer; Roche |
|
|
Travel, Accommodations, Expenses - Boehringer Ingelheim; MSD; Novartis; PharmaMar |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Honoraria - Novartis; Pfizer; Pierre Fabre; Roche |
Consulting or Advisory Role - Daiichi Sankyo; Novartis; Pfizer |
Travel, Accommodations, Expenses - Daiichi Sankyo; Roche |
|
|
|
Consulting or Advisory Role - Bayer; Celgene |
Travel, Accommodations, Expenses - Ipsen; Novartis |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Roche |
Travel, Accommodations, Expenses - Roche |
|
María Ángeles Vaz Salgado |
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
|
Consulting or Advisory Role - Abbvie |
|
|
No Relationships to Disclose |
|
Juan Manuel Sepulveda-Sanchez |
Honoraria - Abbvie; Astellas Oncology; Bayer; Celgene; Pfizer; Roche |
Consulting or Advisory Role - Abbvie; Celgene; Pfizer |
Speakers' Bureau - Astellas Oncology |
Research Funding - Catalysis (Inst); Pfizer (Inst) |
Travel, Accommodations, Expenses - Abbvie; Astellas Oncology; Celgene; Ipsen |